NCT02890758 2023-02-21Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803Case Comprehensive Cancer CenterPhase 1 Completed14 enrolled
NCT03042780 2020-11-27FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine CarcinomasH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated2 enrolled 6 charts